VG Life Sciences Competitors and Similar CompaniesClear all

VG Life Sciences's competitors and similar companies include Epizyme and Oncolytics Biotech.
VG Life Sciences
VG Life Sciences
VG Life Sciences (VGLS, also known as SB Technology Holdings, formerly Viral Genetics) is a company that develops therapeutic and diagnostic pharmaceutical and medical products.
Epizyme
Epizyme
Epizyme is a clinical stage biopharmaceutical company focusing on treatments for blood cancer and tumors.
Oncolytics Biotech
Oncolytics Biotech
Oncolytics Biotech is a company developing Pelareorep, an intravenously delivered immuno-oncolytic virus, used for the treatment of solid tumors and hematological malignancies.
Founding Date
Founding Date
1995
Founding Date
2007
Founding Date
1998
Type
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
New York, US HQ
Locations
Cambridge, US HQ
Locations
Calgary, CA HQ
Calgary, CA
San Diego, US
Employees
Employees
1
Employees
20364% increase
Employees
28
Valuation ($)
Valuation ($)
2.1 m
Valuation ($)
250.8 m
Valuation ($)
93.9 m

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$37.4m (FY, 2021)
Revenue (est.)
N/A
Cost of goods
Cost of goods
N/A
Cost of goods
$10.5m (FY, 2021)
Cost of goods
N/A
Net income
Net income
($6.2m) (FY, 2014)
Net income
($251.1m) (FY, 2021)
Net income
($28.8m) (FY, 2025)

Funding

Total funding raised
Total funding raised
$ 2.8m
Total funding raised
$ 51.5m
Total funding raised
$ 24m
For sources of this data, please see the company profile

View Company Profiles

Epizyme
HQ
Cambridge, US
Employees
203

Epizyme is a clinical stage biopharmaceutical company focusing on treatments for blood cancer and tumors.

View company
Oncolytics Biotech
HQ
Calgary, CA
Employees
28

Oncolytics Biotech is a company developing Pelareorep, an intravenously delivered immuno-oncolytic virus, used for the treatment of solid tumors and hematological malignancies.

View company